UK Oxford-AstraZeneca vaccine study in children paused
Oxford University says it will await additional data on blood clots before resuming trials
06 April 2021 - 23:54
London — Vaccinations of children in a study of the Covid-19 shot developed by AstraZeneca and the University of Oxford have been paused while the UK’s drug regulator investigates rare cases of blood clots in adults.
The vaccine researchers are awaiting the results of a review by the Medicines and Healthcare Products Regulatory Agency, the UK’s drug watchdog, “before further vaccinations”, the university said in an e-mailed statement. No safety issues have arisen in the children’s trial, Oxford said...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.